The United Laboratories International Holdings Limited (FRA:UNJ)

Market Cap	1.53B -46.5%
Revenue (ttm)	1.53B -15.9%
Net Income	69.48M -82.4%
EPS	0.04 -83.7%
Shares Out	n/a
PE Ratio	21.10
Forward PE	11.17
Dividend	0.03 (4.39%)
Ex-Dividend Date	Jul 7, 2026

Volume	1,700
Open	0.7600
Previous Close	0.7650
Day's Range	0.7600 - 0.7600
52-Week Range	0.7600 - 1.5000
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About FRA:UNJ

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 18,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UNJ

Financial Performance

In 2025, FRA:UNJ's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error